<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">108782</article-id><article-id pub-id-type="doi">10.26442/00403660.2022.05.201497</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Activity of ankylosing spondylitis in women within one year after childbirth</article-title><trans-title-group xml:lang="ru"><trans-title>Активность анкилозирующего спондилита у женщин в течение года после родов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1109-9865</contrib-id><name-alternatives><name xml:lang="en"><surname>Krichevskaya</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Кричевская</surname><given-names>Ольга Аркадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>канд. мед. наук, науч. сотр. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1771-6246</contrib-id><name-alternatives><name xml:lang="en"><surname>Dubinina</surname><given-names>Tatyana V.</given-names></name><name xml:lang="ru"><surname>Дубинина</surname><given-names>Татьяна Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>канд. мед. наук, зав. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6354-7244</contrib-id><name-alternatives><name xml:lang="en"><surname>Ilinykh</surname><given-names>Ekaterina V.</given-names></name><name xml:lang="ru"><surname>Ильиных</surname><given-names>Екатерина Валериевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>науч. сотр. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8843-705X</contrib-id><name-alternatives><name xml:lang="en"><surname>Glukhova</surname><given-names>Svetlana I.</given-names></name><name xml:lang="ru"><surname>Глухова</surname><given-names>Светлана Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>ст. науч. сотр. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3106-3296</contrib-id><name-alternatives><name xml:lang="en"><surname>Demina</surname><given-names>Anastasia B.</given-names></name><name xml:lang="ru"><surname>Демина</surname><given-names>Анастасия Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>канд. мед. наук, науч. сотр. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0291-524X</contrib-id><name-alternatives><name xml:lang="en"><surname>Andrianova</surname><given-names>Irina A.</given-names></name><name xml:lang="ru"><surname>Андрианова</surname><given-names>Ирина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>науч. сотр. лаб. аксиального спондилоартрита</p></bio><email>o.krichevskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Nasonova Research Institute of Rheumatology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-06-17" publication-format="electronic"><day>17</day><month>06</month><year>2022</year></pub-date><volume>94</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>647</fpage><lpage>653</lpage><history><date date-type="received" iso-8601-date="2022-06-16"><day>16</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-16"><day>16</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/108782">https://ter-arkhiv.ru/0040-3660/article/view/108782</self-uri><abstract xml:lang="en"><p><bold>Aim. </bold>To assess the dynamics of activity of ankylosing spondylitis (AS) during the year after childbirth, to identify predictors of high activity.</p> <p><bold>Materials and methods. </bold>75 pregnant with confirmed AS (modified New York criteria, 1984) were included for prospective observation. Of these, 44 women were followed up for 1 year after delivery. The average age of the patients was 32.5±5.8 years, the duration of the disease was 149.0±96.3 months. Lactation was established in 40 women and the duration was 10 [4; 12] months.</p> <p><bold>Results.</bold> The BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) at 1, 6 and 12 months after giving birth was 2.4 [1.4; 4.2], 2.6 [1.4; 4.4] and 2.7 [1.5; 4.1], respectively (<italic>p</italic>&gt;0.05). ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score – C-reactive protein) was 2.0 [1.2; 2.7], 1.9 [1.4; 2.5] and 1.7 [1.3; 2.3], respectively (<italic>p</italic>&gt;0.05). There were no differences between the values of BASDAI, ASDAS-CRP between women with and without lactation. Predictors of high AS activity (BASDAI≥4) 1 month after delivery were: BASDAI≥4 in the 1st (odds ratio – OR 8.1; 95% confidence interval – CI 1,8–37,0) and 2nd trimesters of pregnancy (OR 5.1, 95% CI 1.2–20.6); NRS back pain &gt;4 in the 2nd trimester (OR 4.3, 95% CI 1.1–17.2); cancellation of biological disease-modifying antirheumatic drugs therapy in the 1st trimester of pregnancy (OR 21.0, 95% CI 1.0–440.9). Predictors of high AS activity in 6 months after delivery were: BASDAI≥4 in the 1st (OR 6.5, 95% CI 1.5–28.7), in the 2nd (OR 6.7, 95% CI 1.6–27.8) and in the 3rd trimesters of pregnancy (OR 8.7, 95% CI 1.9–38.6); high activity in 1 month after delivery (OR 4.0, 95% CI 1.0–15.9).</p> <p><bold>Conclusion. </bold>AS activity remains stable for 1 year after delivery. High AS activity during pregnancy was a risk factor for high activity within 6 months after delivery.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель. </bold>Оценить активность анкилозирующего спондилита (АС) в течение 1 года после родов, определить факторы риска высокой активности АС.</p> <p><bold>Материалы и методы.</bold> В проспективное наблюдение включены 75 беременных, соответствующих модифицированным Нью-Йоркским критериям АС (1984 г.). Из них в течение 1 года после родов прослежены 44 женщины. Средний возраст пациенток составил 32,5±5,8 года, продолжительность болезни – 149±96,3 мес. Лактация длительностью 10 [4; 12] мес имелась у 40 женщин.</p> <p><bold>Результаты. </bold>Через 1, 6 и 12 мес после родов медиана индекса BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) составила 2,4 [1,4; 4,2], 2,6 [1,4; 4,4] и 2,7 [1,5; 4,1], а медиана индекса ASDAS-CРБ (Ankylosing Spondylitis Disease Activity Score по С-реактивному белку) – 2,0 [1,2; 2,7], 1,9 [1,4; 2,5] и 1,7 [1,3; 2,3] соответственно (<italic>p</italic>&gt;0,05). Не обнаружено различий в значениях BASDAI и ASDAS-CРБ у женщин с лактацией и без нее. Факторы риска высокой активности АС в течение 1 мес после родов: BASDAI≥4 в I (отношение шансов – ОШ, 8,1, 95% доверительный интервал – ДИ, 1,8–37) и II триместрах беременности (ОШ 5,1, 95% ДИ 1,2–20,6); боль в спине &gt;4 по числовой рейтинговой шкале во II триместре (ОШ 4,3, 95% ДИ 1,1–17,2); отмена генно-инженерной биологической терапии в I триместре (ОШ 21, 95% ДИ 1,0–440,9). Предикторы высокой активности через 6 мес после родов: BASDAI≥4 в I (ОШ 6,5, 95% ДИ 1,5–28,7), II (ОШ 6,7, 95% ДИ 1,6–27,8) и III триместрах беременности (ОШ 8,7, 95% ДИ 1,9–38,6); BASDAI≥4 через 1 мес после родов (ОШ 4, 95% ДИ 1,0–15,9).</p> <p><bold>Заключение. </bold>Активность АС в течение 1 года после родов остается стабильной. Высокая активность АС во время беременности является фактором риска высокой активности болезни в течение 6 мес после родов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>ankylosing spondylitis</kwd><kwd>pregnancy</kwd><kwd>postpartum</kwd><kwd>activity</kwd><kwd>BASDAI</kwd><kwd>ASDAS-СRP</kwd><kwd>activity predictors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>анкилозирующий спондилит</kwd><kwd>беременность</kwd><kwd>наблюдение после родов</kwd><kwd>активность</kwd><kwd>BASDAI</kwd><kwd>ASDAS-СРБ</kwd><kwd>предикторы активности</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was conducted as part of the scientific topic No. 398 "Pathogenetic features and personalized therapy of ankylosing spondylitis and psoriatic arthritis" (AAAA-A19-119021190147-6), Nasonova Research Institute of Rheumatology, Moscow, Russia.</funding-statement><funding-statement xml:lang="ru">Исследование проводилось в рамках выполнения научной темы №398 «Патогенетические особенности и персонифицированная терапия анкилозирующего спондилита и псориатического артрита» (АААА-А19-119021190147-6), утвержденной ученым советом ФГБНУ «НИИ ревматологии им. В.А. Насоновой».</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Andreoli L, García-Fernández A, Chiara Gerardi M, Tincani A. The Course of Rheumatic Diseases During Pregnancy. Isr Med Assoc J. 2019;21(7):464-70.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mouyis M. Postnatal Care of Woman with Rheumatic Diseases. Adv Ther. 2020;37(9):3723-31. DOI:10.1007/s12325-020-01448-1</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lui NL, Haroon N, Carty A, et al. Effect of Pregnancy on Ankylosing Spondylitis: A Case-Control Study. J Rheumatol. 2011;38(11):2442-4. DOI:10.3899/jrheum.101174</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ursin K, Lydersen S, Skomsvoll JF, Wallenius M. Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology (Oxford). 2018;57(6):1064-71. DOI:10.1093/rheumatology/key047</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jethwa H, Lam S, Smith C, Giles I. Does Inflammatory Arthritis Really Improve during Pregnancy? A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2019;46(3):245-50. DOI:10.3899/jrheum.180226</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl. 2):ii1-44. DOI:10.1136/ard.2008.104018</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70(2):249-51. DOI:10.1136/ard.2010.133488</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Кричевская О.А., Гандалоева З.М., Глухова С.И., и др. Оценка активности анкилозирующего спондилита во время беременности с использованием различных индексов. Научно-практическая ревматология. 2020;58(5):503-11 [Krichevskaya OA, Gandaloeva ZM, Glukhova SI, et al. Assessment of Ankylosing Spondylitis Activity During Pregnancy Using Different Disease Activity Indices. Rheumatology Science and Practice. 2020;58(5):503-11 (in Russian)]. DOI:10.47360/1995-4484-2020-503-511</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Maguire S, O’Dwyer T, Mockler D, et al. Pregnansy in axial spondyloarthropaty: A systematic review &amp; Meta-Analysis. Semin Arthritis Rheum. 2020;50(6):1269-79. DOI:10.1016/j.semarthrit.2020.08.011</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ostensen M, Romberg O, Husby G. Ankylosing spondylitis and motherhood. Arthritis Rheum. 1982;25(2):140-3. DOI:10.1002/art.1780250204</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ostensen M, Ostensen H. Ankylosing spondylitis – the female aspect. J Rheumatol. 1998;25(1):120-4.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>van den Brandt S, Zbinden A, Baeten D, et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64. DOI:10.1186/s13075-017-1269-1</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Genest G, Spitzer KA, Laskin CA. Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy. J Rheumatol. 2018;45(8):1109-15. DOI:10.3899/jrheum.171152</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Timur H, Tokmak A, Turkmen GG, et al. Pregnancy outcome in patients with ankylosing spondylitis. J Matern Fetal Neonatal Med. 2016;29(15):2470-4. DOI:10.3109/14767058.2015.1089432</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ikram N, Eudy A, Clowse MEB. Breastfeeding in women with rheumatic diseases. Lupus Sci Med. 2021;8:e000491. DOI:10.1136/lupus-2021-000491</mixed-citation></ref></ref-list></back></article>
